Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-18-011288)

Filing Details

Accession Number:: 0001127602-18-011288
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-12 20:59:23
Reporting Period:: 2018-03-08

Accepted Time:: 2018-03-12 20:59:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1083205	U Richard Schutter De	400 Somerset Corporate Boulevard Bridgewater NJ 08807		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2018-03-08	10,000	$15.34	106,062	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $15.01 to $16.00 per share.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range reported above.